CN Patent

CN102286011B — 吡咯烷硼酸酯二肽基肽酶抑制剂及其药物组合物

Assigned to Meide (Jiangxi) Organism Science and Technology Co., Ltd. · Expires 2017-10-03 · 9y expired

What this patent protects

该发明涉及吡咯烷硼酸酯(boronate ester)DDP‑Ⅳ抑制剂，在二肽基肽酶‑Ⅳ参与的疾病如糖尿病尤其是2型糖尿病、肿瘤或其它疾病的治疗和预防中起有益作用。该发明涉及包括这些化合物的药物组合物及其在预防或治疗有二肽基肽酶‑Ⅳ参与的这些疾病中的应用。

USPTO Abstract

该发明涉及吡咯烷硼酸酯(boronate ester)DDP‑Ⅳ抑制剂，在二肽基肽酶‑Ⅳ参与的疾病如糖尿病尤其是2型糖尿病、肿瘤或其它疾病的治疗和预防中起有益作用。该发明涉及包括这些化合物的药物组合物及其在预防或治疗有二肽基肽酶‑Ⅳ参与的这些疾病中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102286011B
Jurisdiction
CN
Classification
—
Expires
2017-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Meide (Jiangxi) Organism Science and Technology Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.